Sale!

Research Paper on Targeting Vascular and Other Pathologies by Inhibiting NADPH Oxidases: An Update on Recent Experimental and Clinical Studies

Original price was: ₹21,240.00.Current price is: ₹10,620.00. inc. GST

Research Paper on Targeting Vascular and Other Pathologies by Inhibiting NADPH Oxidases: An Update on Recent Experimental and Clinical Studies

1 in stock

Description

Title: Targeting Vascular and Other Pathologies by Inhibiting NADPH Oxidases: An Update on Recent Experimental and Clinical Studies

Abstract: In terms of health and disease, reactive oxygen species (ROS) can be advantageous or detrimental. Elevated levels of ROS cause a number of pathologies, including endothelial dysfunctions, colon cancer, and fibrosis, whereas low levels of ROS act as signaling molecules to control vascular tone and the growth and proliferation of endothelial cells. Numerous studies have been conducted on ROS and the cellular sources of these compounds as potential clinical intervention targets. Four NADPH oxidases (NOX1, NOX2, NOX4, and NOX5) play a significant role in homeostasis and disease, whereas different ROS sources are significant for various pathologies. NOX1 inhibition may be a promising therapeutic strategy because NOX1-generated ROS have been linked to hypertension. Due to their function in the production of extracellular and intracellular hydrogen peroxide, NOX2 and NOX4 oxidases are of particular interest (H2O2). The ROS-induced ROS release (RIRR) signaling is caused by hydrogen peroxide released by NOX4 activating NOX2, which in turn stimulates the release of mitochondrial ROS. NOX5’s increased ROS production causes atherosclerosis. In order to treat pathologies like diabetes, idiopathic pulmonary fibrosis (IPF), and primary biliary cholangitis, recent research on NOX enzymes and clinical trials inhibiting NADPH oxidases has been compiled in this review (PBC).

Keywords: ROS; NADPH oxidase; NOX

Paper Quality: SCOPUS / Web of Science Level Research Paper

Subject: Biomolecules

Writer Experience: 20+ Years

Plagiarism Report: Turnitin Plagiarism Report will be less than 10%

Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.

What will I get after the purchase?

A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.

In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.